Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.35 +0.12 (+0.79%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Shares Outstanding (Entity) (2020 - 2026)

Updated

Cullinan Therapeutics' Shares Outstanding (Entity) came in at 64.35 million for Q2 2026, up 8.9% from 59.07 million a year earlier and up 4.7% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics' Shares Outstanding (Entity) was 60.24 million, up 3.0% from FY2024.

  • Shares Outstanding (Entity) carries a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 58.51 million in FY2024 (+36.4%), 42.9 million in FY2023 (-6.3%), 45.8 million in FY2022 (+3.4%) and 44.29 million in FY2021 (+122.7%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2020.
  • Year-over-year, Shares Outstanding (Entity) has increased for ten consecutive quarters, with growth averaging 16.1% over the last eight quarters.
  • The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q4 2021 (growth of 122.7%), and the weakest in Q1 2023 (a decline of 11.9%).
  • Business Quant data shows CGEM's Shares Outstanding (Entity) at 61.45 million (Q1 2026), 60.24 million (Q4 2025) and 59.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - 64.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64.35 Mn
Mar 31, 2026 61.45 Mn
Dec 31, 2025 60.24 Mn
Sep 30, 2025 59.08 Mn
Jun 30, 2025 59.07 Mn
Mar 31, 2025 58.70 Mn
Dec 31, 2024 58.51 Mn
Sep 30, 2024 58.14 Mn
Jun 30, 2024 57.87 Mn
Mar 31, 2024 43.07 Mn
Dec 31, 2023 42.90 Mn
Sep 30, 2023 42.76 Mn
Jun 30, 2023 42.74 Mn
Mar 31, 2023 39.34 Mn
Dec 31, 2022 45.80 Mn
Sep 30, 2022 45.74 Mn
Jun 30, 2022 45.40 Mn
Mar 31, 2022 44.66 Mn
Dec 31, 2021 44.29 Mn
Sep 30, 2021 43.66 Mn
API Access

Cullinan Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CGEM&period=max&api_key=YOUR_API_KEY